icg draft 10jan10
TRANSCRIPT
-
8/2/2019 ICG Draft 10jan10
1/210
AUSTRALIANGUIDELINESFORTHE
PREVENTIONANDCONTROLOF
INFECTIONINHEALTHCARE
CONSULTATIONDRAFT
7JANUARY 2010
-
8/2/2019 ICG Draft 10jan10
2/210
CONSULTATIONDRAFTJANUARY2010
Contents
2
Contents
Summaryofrecommendations.................................................................................................................... 7
Introduction .................................................................................................................................................. 13
PART A BASICS OF INFECTION CONTROL..................................... .................................................... .......................... 19
A1 Infectioncontrolinthehealthcaresetting...................................................................................... 20
A1.1 Risksofcontractingahealthcareassociatedinfection.......................................................... 20
A1.2 Standardandtransmissionbasedprecautions...................................................................... 22
A2 Overviewofriskmanagementininfectionpreventionandcontrol ......................................... 24
A2.1 Riskmanagementbasics ....................................................... .................................................... 24
A3 Apatientcentredapproach ........................................................... .................................................... 26
A3.1 Patientcentredhealthcare ....................................................................................................... 26
A3.2 Howdoespatientcentredcarerelatetoinfectioncontrol?.................................................. 26
PART B STANDARD AND TRANSMISSION-BASED PRECA UTIONS.......... ............................................ ................. ........ 28B1 Standardprecautions.......................................................................................................................... 29
B1.1 Handhygieneandcoughetiquette ......................................................................................... 30
B1.2 Personalprotectiveequipment ................................................................................................ 36
B1.3 Handlinganddisposingofsharps........................................................................................... 47
B1.4 Routinemanagementofthephysicalenvironment .............................................................. 51
B1.5 Processingofinstrumentsandequipment .................................................................. ........... 63
B2 Transmissionbasedprecautions...................................................................................................... 69
B2.1 Applicationof
transmission
based
precautions .................................................................... 70
B2.2 Contactprecautions .................................................. ............................................................ ..... 71
B2.3 Dropletprecautions .................................................. ............................................................ ..... 74
B2.4 Airborneprecautions................................................................................................................. 77
B2.5 Puttingitintopractice ......................................................... ...................................................... 80
B3 Managementofresistantorganismsandoutbreaksituations.................................................... 89
B3.1 Managementofmultiresistantorganisms............................................................................. 90
B3.2 Outbreakinvestigationandmanagement ..................................................................... ......... 99
B3.3 Puttingit
into
practice ......................................................... .................................................... 106
B4 applyingstandardandtransmissionbasedprecautionsduringprocedures......................... 107
B4.1 Takingariskmanagementapproachtoprocedures........................................................... 108
B4.2 Therapeuticdevices .............................................................. ................................................... 110
B4.3 Surgicalprocedures ............................................................ ..................................................... 121
B4.4 Puttingitintopractice ......................................................... .................................................... 125
-
8/2/2019 ICG Draft 10jan10
3/210
CONSULTATIONDRAFTJANUARY2010
Contents
3
PART C ORGANISATIONAL SUPPORT.......................... .................................................... .......................................... 126
C1 Managementandclinicalgovernance .................................................. ......................................... 127
C1.1 Clinicalgovernanceininfectioncontrol ...................................................................... ......... 127
C1.2 Rolesandresponsibilities........................................................................................................ 129
C1.3 Infectionpreventionandcontrolprogram .............................................................. ............. 131
C1.4 Riskmanagement..................................................................................................................... 133
C1.5 Takinganorganisationalsystemsapproachtoriskmanagement .................................... 134
C2 Staffhealthandsafety...................................................................................................................... 136
C2.1 Rolesandresponsibilities........................................................................................................ 136
C2.2 Healthstatusscreeningandimmunisation.......................................................................... 137
C2.3 Exclusionperiodsforhealthcareworkerswithacuteinfections....................................... 138
C2.4 Healthcareworkerswithspecificcircumstances................................................................. 140
C2.5 Exposureproneprocedures ................................................................................................... 141
C2.6 Occupationalhazardsforhealthcareworkers ..................................................................... 142
C3 Educationandtraining ........................................................... .......................................................... 145
C3.1 Teachingfacilities..................................................................................................................... 145
C3.2 Healthcarefacilities.................................................................................................................. 147
C3.3 Educationstrategies................................................................................................................. 148
C3.4 Exampleofeducationinpracticehandhygiene............................................................. 148
C3.5 Complianceandaccreditation................................................................................................ 150
C3.6 Patientengagement.................................................................................................................. 150
C4 Healthcareassociatedinfectionsurveillance............................................................................... 152
C4.1 RoleofsurveillanceinreducingHAI.................................................................................... 152
C4.2 Typesofsurveillanceprograms............................................................................................. 153
C4.3 Datacollectionandmanagement........................................................................................... 154
C4.4 Outbreaksurveillance ............................................................................................................. 155
C4.5 Diseasesurveillanceinofficebasedpractice ....................................................................... 155
C4.6 Notifiablediseases .......................................................... ......................................................... 156
C5 Antibioticstewardship..................................................................................................................... 157
C5.1 Background............................................................................................................................... 157
C5.2 Antibioticstewardshipprograms.......................................................................................... 158
C5.3 Antibioticstewardshipsurveillancemethods...................................................................... 159
C6 Influenceoffacilitydesignonhealthcareassociatedinfection ............................................... 161
C6.1 Facilitydesignanditsimpactoninfectioncontrol.............................................................. 161
C6.2 Mechanismsforinfluencinghealthcareassociatedinfectionthroughenvironmental
design......................................................................................................................................... 162
C6.3 Thebenefitsofsinglebedroomsforpatientisolation....................................................... 166
C6.4 Constructionandrenovation................................................................................................. 167
C6.5 Guidancedocuments............................................................................................................... 167
-
8/2/2019 ICG Draft 10jan10
4/210
CONSULTATIONDRAFTJANUARY2010
Contents
4
PART D STANDARDS, LEGISLATION A ND OTHER RESOURCES......................... ............................................ ............. 168
D1 Generalinfectioncontrolresources........................................................................................ 169
D2 Standardprecautions................................................................................................................ 170
D3 Transmissionbasedprecautions ............................................................................................ 172
D4 Devicemanagement ................................................................ ................................................. 173
D5 Involvingpatientsintheircare ....................................................... ........................................ 174
D6 Staffhealthandsafety ............................................................. ................................................. 175
D7 Surveillance................................................................................................................................ 175
D8 Facilitydesign............................................................................................................................ 176
APPENDICES...................................................................................................................................................................177
1 MembershipandTermsofreferenceoftheWorkingCommittee............................................. 178
2 Processreport ....................................................... ........................................................... ..................... 180
3 Exposureproneprocedures(EPP) .......................................................... .......................................... 189
Glossary ............................................................... ........................................................... ............................. 194
Abbreviationsandacronyms ....................................................... ............................................................ 200
References.................................................................................................................................................... 202
List of tables and figures
Tab les
Table1: Directoryofkeyinformationintheseguidelines ......................................................... ...................... 11
Table2: Sourcesofevidencetosupportrecommendations............................................................................. 14Table3: NHMRCgradesofevidence.................................................................................................................. 16
Table4: Keytotypesofinformationhighlightedintheguidelines................................................................ 17
Table5: Topicsdiscussedintheguidelines........................................................................................................ 18
TableA1.1: Howstandardprecautionsareimplemented...................................................................................... 22
TableA1.2: Strategiesforimplementingtransmissionbasedprecautions .......................................................... 23
TableA2.1: Riskanalysismatrix .......................................................... ............................................................... ....... 24
TableB1.1: Stepsincoughetiquette.......................................................................................................................... 32
TableB1.2: Useofalcoholbasedhandrub.............................................................................................................. 33
TableB1.3: Usingsoap(includingantimicrobialsoap)andwater....................................................................... 33
TableB1.4: Characteristicsofaprons/gowns ................................................................ ........................................... 37
TableB1.5: Useoffaceandeyeprotectionaspartofstandardprecautions ....................................................... 38
TableB1.6: Propertiesofdifferenttypesofmask.................................................................................................... 38
TableB1.7: Selectionofglovetype............................................................................................................................ 41
TableB1.8: PuttingonandremovingPPE............................................................................................................... 43
Table
B1.9: Reducing
risks
if
a
sharps
injury
is
sustained ..................................................... ................................ 48TableB1.10:Characteristicsofdisinfectants.............................................................................................................. 52
-
8/2/2019 ICG Draft 10jan10
5/210
CONSULTATIONDRAFTJANUARY2010
Contents
5
TableB1.11:Managementofbloodorbodysubstancespills.................................................................................. 55
TableB1.12 Recommendedroutinecleaningfrequenciesforclinical,patientandresidentareas.................... 56
TableB1.13:Categoriesofitemsforpatientcare .......................................................... ............................................ 63
TableB1.14:Generalcriteriaforreprocessingandstorageofequipmentandinstrumentsinhealthcaresettings...................................................................................................................................................... 66
TableB2.1: Applicationofstandardandtransmissionbasedprecautions ......................................................... 81
TableB2.2: Infectionswarrantingtransmissionbasedprecautionsbeforelaboratoryconfirmationofinfection ............................................................... .............................................................. ....................... 82
TableB2.3: Typeanddurationofprecautionsforspecificinfectionsandconditions ....................................... 83
TableB3.1 SuggestedapproachtoscreeningforMRSA....................................................................................... 93
TableB3.2 SuggestedapproachtoscreeningforVREandMRGNdependentonlocalacquisitionrates..... 94
TableB3.3: ExampleofasuccessfulstrategytopreventendemicityofMRSAinatertiaryhospitalinWA .96
TableB3.4: ExampleofasuccessfulstrategytopreventendemicityofVREinatertiaryhospitalinWA.....96
TableB3.5: Stepsinanoutbreakinvestigation...................................................................................................... 100
TableB4.1: Levelofrisktopatientsfromdifferenttypesofprocedures........................................................... 108
TableB4.2: Summaryofprocessesforappropriateuseofdevices..................................................................... 109
TableB4.3: Keyconceptsinminimisingtheriskofinfectionrelatedtotheuseofinvasivedevices ............ 110
TableB4.4: Summaryofprocessesforurethralcatheterinsertionandmaintenance ...................................... 112
TableB4.5: CAUTImaintenancebundle ................................................... ........................................................... .. 113
TableB4.6: RiskfactorsforIVDrelatedBSI .......................................................................................................... 114
TableB4.7: Central
venous
catheter
decision
tree
for
adults............................................................................... 114
TableB4.8: Summaryofprocessesforinsertionandmaintenanceofintravascularaccessdevices..............117
TableB4.9: SummaryofstrategiesforpreventingVAP ...................................................................................... 119
TableB4.10:VAPcarebundle......................................... ................................................................ ........................... 119
TableB4.11:Summaryofprocessesforusingenteralfeedingtubes.................................................................... 120
TableB4.12:Summaryofprocessespresurgicalprocedure ............................................................... .................. 122
TableB4.13:Summaryofprocessesduringasurgicalprocedure ................................................................ ........ 123
TableB4.14:Summaryofprocessesfollowingasurgicalprocedure ........................................................... ........ 124
TableB4.15:Checklistofstandardprecautionsforprocedures............................................................................ 125
TableC1: Recommendedvaccinationsforallhealthcareworkers .................................................................. 138
TableC2: Staffexclusionperiodsforinfectiousillnesses.................................................................................. 139
TableC3: Categoriesofexposureproneprocedures ...................................................... ................................... 141
TableC4: Keyrequirementsofahospitalantibioticstewardshipprogram................................................... 158
TableApp2.1:Clinicalquestionsforsystematicreview......................................................................................... 183
Figures
FigureA1.1:Riskmanagementflowchart ............................................................ ...................................................... 25
FigureB1.1: Importanceofhandhygiene.................................................................................................................. 30
FigureB1.2: The5momentsofhandhygiene........................................................................................................... 31
-
8/2/2019 ICG Draft 10jan10
6/210
CONSULTATIONDRAFTJANUARY2010
Contents
6
FigureB1.3: Processesforroutinecleaning ............................................................. .................................................. 51
-
8/2/2019 ICG Draft 10jan10
7/210
CONSULTATIONDRAFTJANUARY2010
Summary of rec omme nda tions
7
SUMMARY OF RECOMMENDATIONS
Theseguidelinesproviderecommendationsthatoutlinethecriticalaspectsofinfectionpreventionand
control.TherecommendationsweredevelopedbytheInfectionControlSteeringCommittee1basedon
systematicreviewsoftheliteratureundertakenspecificallyfortheseguidelinesoronguidelinesdeveloped
byotheradvisorybodies.Theyshouldbereadinthecontextoftheevidencebase.Thisisdiscussedin
SectionsB1,B2andB3,whichalsoincludeadviceonthepracticalapplicationoftherecommendations.The
tablebelowlistsrecommendationsandthesectionoftheguidelinesinwhichtheyarediscussed.
Rec om me nda tion Refer to:
Standard preca utions
Hand hygiene
1 Routine hand hyg iene
Hand hygiene must b e p erformed before and after every episode of pa tient c ontac t.
This inc lud es:
before touching a pa tient;
before a proced ure;
a fter a p roced ure or bod y fluid exposure risk;
after touching a pa tient; and
after touching a patients surroundings.
Hand hygiene must a lso b e p erformed after rem ova l of gloves.
Sec tion B1.1.2
Page 30
2 Choice of produc t for routine hand hygiene prac tices
Alcoho l-ba sed hand rubs c onta ining at least 70% v/ v etha nol or equivalent should b e
used for all routine hand hygiene p rac tices in the hea lthcare environm ent.
Sec tion B1.1.3
Page 32
3 Choice of hand hygiene produc t when hands are visibly soiled
If hand s a re visibly soiled, hand hygiene should b e performed using soa p a nd w ater.
Sec tion B1.1.3
Page 32
Personal protective equipment
4 Wearing of ap rons/ gow ns
Ap rons or gow ns should b e a pp rop riate to the ta sk being und ertaken. They should b e
wo rn for a single p roc ed ure or episod e of p atient c are and remo ved in the area
where the ep isod e of ca re takes plac e.
Sec tion B1.2.3
Page 37
5 Use of face and eye protection for proce dures
A surgica l mask and go gg les must b e wo rn d uring p roc ed ures that ge nerate ae rosols,
sp lashes or sp rays of b lood , bo dy fluids, sec retions or excretions into the fac e a nd eyes.
Sec tion B1.2.4
Page 38
6 Wearing of gloves
Glove s must b e wo rn as a single-use item for:
each invasive procedure;
c onta c t with sterile sites and no n-inta c t skin or muc ous me mb ranes; and
any ac tivity tha t has been assessed as c arrying a risk of exposure to bloo d, bod y
fluids, secretions and excretions.
Gloves must be c hang ed be twee n pa tients and after every ep isod e of individua l
pa tient ca re.
Sec tion B1.2.5
Page 40
1 MembershipandtermsofreferenceoftheInfectionControlSteeringCommitteearegiveninAppendix1.
-
8/2/2019 ICG Draft 10jan10
8/210
CONSULTATIONDRAFTJANUARY2010
Summary of rec omme nda tions
8
Rec om me nda tion Refer to:
7 Sterile glo ves
Sterile gloves must b e used for asep tic p roce dures and c onta c t w ith sterile sites.
Sec tion B1.2.5
Page 40
Handling and disposal of sharps
8 Safe hand ling of sharpsSharps must not b e p assed direc tly from hand to ha nd a nd ha ndling should b e kep t to
a minimum .
Need les must not be rec ap pe d, b ent, broken or d isassemb led a fter use.
Sec tion B1.3.2Page 47
9 Dispo sal of sharps
The person who has used the sha rp must b e respo nsible fo r its imme dia te safe d isposal.
Used sha rps must be disc arde d into a n ap prove d sha rps c onta iner a t the p oint-of-use.
These m ust no t b e filled abo ve the m ark that indica tes the b in is three-qua rters full.
Sec tion B1.3.3
Page 48
Routine environmental cleaning
10 Routine c leaning of surfac es
Clean freque ntly touc hed surfac es with de tergent solution a t least d aily, and whe n
visibly soiled and after eve ry known c onta mination.
Clea n ge neral surfac es and fittings whe n visibly soiled a nd imm ed iate ly a fter sp illage .
Sec tion B1.4.2
Page 51
11 Cleaning of shared c linica l equipm ent
Clean to uche d surfac es of shared c linic al eq uipment b etw een p atient uses, with
detergent solution.
Exce p tions to this should be justified by risk assessme nt.
Sec tion B1.4.2
Page 51
12 Surfac e ba rriersUse surfac e b a rriers to p rote c t c linica l surfac es (inc luding equ ipment) tha t are:
touc hed freque ntly with gloved hand s during the d elivery of pa tient ca re;
likely to bec om e c onta minated with blood o r bo dy substanc es; or
diffic ult to c lean (e.g. com pute r keyboa rds).
Exce p tions to this should be justified by risk a ssessme nt.
Sec tion B1.4.2Page 51
13 Site de c ontam ination after spills of bloo d or other po tentially infec tious ma terials
Spills of b lood or other po tentia lly infec tious ma terials should b e p romp tly c leaned as
follows:
wear utility gloves and other PPEap propriate to the ta sk;
co nfine a nd c ontain spill, clean visible ma tter with dispo sab le ab sorbe nt ma terial
and disc ard the used c leaning ma terials in the ap propriate wa ste c onta iner;
clean the sp ill area w ith a c loth or pa per towels using dete rge nt solution.
Use o f che mic al d isinfec ta nts suc h as sod ium hypo c hlorite should be based on
assessme nt of risk of transmission of infe c tious ag ents from tha t sp ill.
Sec tion B1.4.3
Page 54
Transmission- ba sed prec autions (see Sec tion B2)
Contact precautions
-
8/2/2019 ICG Draft 10jan10
9/210
CONSULTATIONDRAFTJANUARY2010
Summary of rec omme nda tions
9
Rec om me nda tion Refer to:
14 Impleme ntation of c ontac t preca utions
In ad dition to stand ard p rec autions, imp lement c onta c t prec autions in the presenc e
of known o r suspe c ted infec tious ag ents that a re sprea d by d irec t or indirec t c onta c t
with the pa tient or the p atient s environme nt.
Sec tion B2.2.2
Page 71
15 Hand hygiene and pe rsonal protec tive equipm ent to prevent contac t transmission
When working with pa tients who req uire c onta c t p rec autions:
perform hand hygiene;
put on g loves and gow n upon entry to the pa tient ca re a rea ;
ensure that c lothing a nd skin do not c onta c t pote ntially c onta minated
environme nta l surfac es; and
remove gow n and gloves and perform ha nd hygiene before leaving the pa tient
ca re area.
Sec tion B2.2.3
Page 71
16 Hand hygiene when Clostridium difficileis suspe c ted o r known to be p resent
To fa c ilitate the m ec hanica l rem ova l of spores, meticulously wash hands with soa p
and wa ter and pa t d ry with single-use to wels.
Use o f alc oho l-ba sed hand rubs alone ma y not b e sufficient to red uc e transmission of
Clostridium difficile.
Sec tion B2.2.3
Page 71
17 Patient c are equipm ent for pa tients on contac t preca utions
Use p atient d ed ica ted eq uipment o r single-use non-critic al pa tient ca re eq uipment
(e.g. b lood p ressure c uffs).
If co mm on use of e quipm ent for multiple p atients is unavo idab le, c lean the e quipm ent
and allow it to dry before use on a nother pa tient.
Sec tion B2.2.3
Page 72
Droplet precautions
18 Impleme ntation of droplet preca utions
In a dd ition to stand ard p rec autions, imp lem ent d rop let prec autions for patients known
or suspec ted to b e infec ted with ag ents transmitted by respirato ry drop lets (ie large-
particle droplets >5 in size) that a re ge nerated by a p atient whe n co ughing,
snee zing, ta lking, o r during suc tioning.
Sec tion B2.3.2
Page 74
19 Persona l protec tive eq uipment to prevent drop let transmission
When entering the pa tient ca re e nvironme nt, put on a surgic al ma sk.
Sec tion B2.3.3
Page 74
20 Plac em ent of pa tients requiring drop let prec autions
Place pa tients who req uire d rop let prec autions in a single-patient room when
available.
Sec tion B2.3.3
Page 75
Airborne precautions
21 Impleme ntation of airborne preca utions
In a dd ition to stand ard p rec autions, imp leme nt a irbo rne p rec autions for patients
known or suspected to be infected with infectious agents transmitted person-to-person
by the airborne route (ie airborne drop let nuc lei or pa rticles
-
8/2/2019 ICG Draft 10jan10
10/210
CONSULTATIONDRAFTJANUARY2010
Summary of rec omme nda tions
10
Rec om me nda tion Refer to:
23 Plac em ent of pa tients requiring airborne prec autions
Pat ients on a irborne p reca utions should be pla c ed in nega tive p ressure roo ms or in a
room from which the air do es not c irc ulate to o ther area s.
Exce p tions to this should be justified by risk assessme nt.
Sec tion B2.4.3
Page 78
Multid rug resistant o rganisms (see Sec tion B3)
24 Imp leme ntation of co re strategies in the control of multi-resistant organisms (MRSA,
MRGN, VRE)
Imp lement transmission-ba sed prec autions for all pa tients c olonised or infec ted with a
multi-resistant organism, including:
putting on gloves and go wns be fore entering the pa tient ca re area;
using pa tient ded ica ted or single-use non-c ritic al pa tient ca re e quipm ent
(e.g. bloo d p ressure cuff, stethosc op e);
using a single-pa tient roo m o r, if unava ilab le, coho rting p a tients with the sam e
strain of m ulti-resista nt o rga nism in d esigna ted pa tient c are a reas; and
ensuring c onsistent c leaning and d isinfec tion o f surfac es in close p roximity to the
pa tient and tho se likely to be to uche d b y the pa tient and he althca re wo rkers.
Sec tion B3.1.2
Page 91
-
8/2/2019 ICG Draft 10jan10
11/210
CONSULTATIONDRAFTJANUARY2010
Summary of rec omme nda tions
11
Finding information
Theserecommendationsprovidethebasisforappropriateinfectioncontrolpracticeinthehealthcaresetting.
PracticalguidanceontheirimplementationisgiveninPartBoftheseguidelines.Thefollowingtable
providesadirectoryforthisguidance.
Tab le 1: Directo ry of key informa tion in these guid elines
WHEN YOU NEED TO KNOW READ PAGE
Infec tion control ba sics
What are standard precautions and how are they ap plied Basics p29
How are transmission-based precautions app lied Basics p70
How to help patients become involved in infection co ntrol Sec tion A3;
Patient care tips also highlighted
How to a pp ly the p roce ss of risk management Sec tion A2; Case studies pp35, 46, 50, 61,
73, 75, 79, 98, 105
Hand hygiene and c ough etiquette
When to pe rform hand hygiene Basics p30; Contac t 71; Drop let p 74; MROs p90
What hand hygiene products to use and how Basics pp 32 to 33; Ca se study p 35; MROs p90
What to d o if there are cuts or ab rasions on y our hands Basics p33
Aboutjewe llery or artificial fingernails and infec tion Basics p33
How to ca re for your hand s Basics pp33 to 34
How to p rac tice cough etiquette Basics p32
Personal p rotective e quipm ent
How to dec ide wha t PPE is need ed for a pa rtic ular situation Basics p36
What PPE to we ar for routine clinical practice Stand ard p 71;
What PPE to w ea r when there is a risk of co nta mina tion with
blood, body fluids, secretions, or excretions
Ap rons and go wns p37, fac e and e ye protection p38;
gloves p40
What PPE to w ea r when transmission-ba sed prec autions are
implemented
Contact p71; Droplet p74; Airbo rne p77;
MROs p91; Summa ry p81
When to wea r aprons and g owns Basics p37; Contac t 71
When to wea r face and e ye protection Basics p38; Airbo rne 77
When to wea r gloves Basicsp40; Contac t 71; Ca se study p 46
What is the c orrec t proc ed ure for putting on and removing PPE Basics p43
Hand ling and disposal of sharps
How to avoid sharps injuries Basics p47 ; Ca se study p 50
How to use need leless devic es Basics p49
How to safe ly dispose of sha rps Basics p48
What to do if a sharps injury is sustained Basics p48
-
8/2/2019 ICG Draft 10jan10
12/210
CONSULTATIONDRAFTJANUARY2010
Summary of rec omme nda tions
12
Environmental cleaning
What p roduc ts and proc esses to use for routine e nvironme ntal
cleaning of surface s
Basics p51, p56
When to use disinfectants Basics p52; MROs p91
How to m inimise c onta mination of c leaning implem ents and
solutions
Basics p53
What products and processes to use when there is a spill of blood
or body fluids
Basics p54; Ca se study p 61
Processing of instruments and equipment
How to clean eq uipment and instruments Metho ds p63; Agents 64
How to disinfect eq uipment and instruments Metho ds p64
How to sterilise eq uipment and instruments Metho ds p65
How to dec ide which proc essing is req uired Basics p63; 66; Ca se study p 68
When there is a suspec ted o r co nfirmed infection
What transmission-based precautions are required for a specific
infec tious ag ent
Summ ary p81, p83
When to implement transmission-ba sed prec autions Gene ral p82; Contac t p71; Droplet p74; Airborne p77
When to impleme nt the use of single-use or dedicated patient
care equipment
Contact p72; MROs p91
What to consider when transporting pa tients Contac t p73; Droplet p75; Airborne p78
Where to place p atients to avoid cross-contam ination Contac t p72; Droplet p75; Airbo rne p78;
MROs p91; Outbreak p103
-
8/2/2019 ICG Draft 10jan10
13/210
CONSULTATIONDRAFTJANUARY2010
Introduction
13
INTRODUCTION
Effectiveinfectioncontrolpreventingthetransmissionofinfectiousorganismsandmanaginginfectionsif
theyoccuriscentraltoprovidinghighqualityhealthcareforpatientsandasafeworkingenvironmentfor
thosethatworkinhealthcaresettings.
Healthca re-assoc iated infec tion is preventable
Therearearound200,000healthcareassociatedinfections(HAIs)inAustralianacutehealthcarefacilities
eachyear.ThismakesHAIsthemostcommoncomplicationaffectingpatientsinhospital.Aswellascausing
unnecessarypainandsufferingforpatientsandtheirfamilies,theseadverseeventsprolonghospitalstays
andarecostlytothehealthsystem.Theproblemdoesnotjustaffectpatientsandworkersinhospitals
HAIscanoccurinanyhealthcaresetting,includingofficebasedpractices(e.g.generalpracticesurgeries,
dentalclinics)andlongtermresidentialcarefacilities(seeGlossary).Anypersonworkinginorenteringa
healthcarefacilityisatrisk.However,healthcareassociatedinfectionisapotentiallypreventableadverse
eventratherthananunpredictablecomplication.ItispossibletosignificantlyreducetherateofHAIs
througheffectiveinfectioncontrol.
Infec tion control is eve rybod ys businessUnderstandingthemodesoftransmissionofinfectiousorganismsandknowinghowandwhentoapplythe
basicprinciplesofinfectioncontroliscriticaltothesuccessofaninfectioncontrolprogram.This
responsibilityappliestoeverybodyworkingandvisitingahealthcarefacility,includingadministrators,
staff,patientsandcarers.
SuccessfulapproachesforpreventingandreducingharmsarisingfromHAIsinvolveapplyingarisk
managementframeworktomanagehumanandsystemfactorsassociatedwiththetransmissionof
infectiousagents.Thisapproachensuresthatinfectiousagents,whethercommon(e.g.gastrointestinal
viruses)orevolving(e.g.influenzaormultiresistantorganisms[MROs]),canbemanagedeffectively.
Development of the guidelines
AspartoftheAustralianCommissiononSafetyandQualityinHealthCares(ACSQHC)coordinated
approachtothepreventionandcontrolofHAIs,theNationalHealthandMedicalResearchCouncil
(NHMRC)wasaskedtodevelopguidelinestoprovidenationalguidanceforthecontrolofHAIsandalsoa
foundationbywhichotherstrategiesaddressingthepriorityareaofHAIscanbeimplemented.
TheNHMRCappointedanexpertgrouptoguidethedevelopmentprocess(SteeringCommittee
membershipandtermsofreferencearegiveninAppendix1).Theguidelinesarebasedonthebestavailable
evidence.Theybuildonexistingguidelinesandreviews,aswellassystematicreviewsoftheevidence.
Aim
Byassistinghealthcareworkerstoimprovethequalityofthecaretheydeliver,theseguidelinesaimto
promote
and
facilitate
the
overall
goal
of
infection
control:
Thecreationofsafehealthcareenvironmentsthroughtheimplementationofpracticesthatminimisetheriskof
transmissionofinfectiousagents.
Scope
Thescopeoftheseguidelineswasestablishedatthestartoftheguidelinedevelopmentprocess,followinga
periodofconsultationthatincludedforumsinvolvingawiderangeofstakeholders(seeAppendix2).
Theguidelinesweredevelopedtoestablishanationallyacceptedapproachtoinfectioncontrol,focusingon
coreprinciplesforinfectioncontrolandpriorityareasforaction.Theyprovideabasisforhealthcareworkers
andhealthcarefacilitiestodevelopdetailedprotocolsandprocessesforinfectioncontrolthatapplytotheir
specificsituation.
Whiletheguidelinesfocusonacutecare,theriskapproachusedtoaddresstheprinciplesofinfectioncontrol
meanstheyareapplicabletoawiderangeofhealthcaresettings,includingofficebasedpractice,residential
-
8/2/2019 ICG Draft 10jan10
14/210
CONSULTATIONDRAFTJANUARY2010
Introduction
14
carefacilities,Aboriginalmedicalservices,homeandcommunitynursingandemergencyservices.Materials
thatidentifyrelevantrisksandmakerecommendationsonorganisationalpoliciesandproceduresforother
settingswillalsobedeveloped,basedontheprinciplesoutlinedintheseguidelines.Informationforpatients
willalsobederivedfromtheseguidelines.
Theguidelinesdonotincludedetailedinformationon:
infectiousdiseases;
pandemicplanning;
thereprocessingofinstruments;
occupationalhealthandsafety;
hospitalhotelservicessuchasfoodservices,laundryservicesorwastedisposal;or
engineering/healthfacilitydesign.
TheguidelinesdonotduplicateinformationprovidedinexistingAustralianStandardsbutrefertospecific
standardswhereverrelevant.
Target audienc e
Theguidelines
are
for
use
by
all
those
working
in
healthcare
this
includes
healthcare
workers,
managementandsupportstaff.
Evidence base
Theseguidelinesarebasedonthebestavailableevidenceandknowledgeofthepracticalitiesofclinical
procedures.Theydrawfromotherworkinthisarea,includingthetwopreviousnationalinfectioncontrol
guidelines,2internationalinfectioncontrolguidelines,systematicliteraturereviewsconductedtoinformthe
developmentoftheseguidelines,workonHAIpreventionfromACSQHC,andAustralianStandards
relevanttoinfectioncontrol.Australiandataareusedwhereveravailable.
Tab le 2: Source s of evidenc e to supp ort reco mm endations
Systematic ally de velope d international guidelines3
World Health Organization
Guidelines on ha nd hygiene in hea lth ca re (2009)
United States Centers for Disea se C ontrol a nd Prevention
Workbo ok for d esigning, imp lementing a nd eva luating a sharps injury p revention prog ram (2009)
Guideline for isola tion p recautions: preventing tra nsmission of infec tious age nts in hea lthca re setting s (2007)
Management of multidrug-resistant organisms in healthcare settings (2006)
Guidelines for infection control in the dental setting (2003)
Guidelines for environmental infection control in health-care facilities (2003)
United Kingdom National Institute for Health and Clinical Excellence
Surgica l site infect ion prevention a nd t rea tme nt of surgica l site infect ion (2008)
Prevention of hea lthcare-assoc iated infection in prima ry and c omm unity care (2003)
UK Dep artme nt of Health
Epic 2: Nat ional evidenc e-b ased g uide lines for preve nting hea lthca re-assoc iated infec tions in NHS hospitals inEngla nd (2007)
British Soc iety for Antimicrob ial Chem otherapy
Guidelines for UK practice for the diagnosis and management of methicillin-resistant Stap hyloc oc cus aureus
(MRSA) infec tions presenting in the c om mun ity
Guidelines for the m ana ge ment of ho spital-ac quired pne umonia in the UK: Rep ort of the Working Party on
Hospita l-Ac qu ired Pneum onia o f the British Soc iety for Antimic rob ial Che mo the rap y
2 CDNA(2004)InfectionControlGuidelinesforthePreventionofTransmissionofInfectiousDiseaseintheHealthCareSetting.
CommunicableDiseasesNetworkofAustralia.
NHMRC(1996)InfectionControlintheHealthcareSetting.GuidelinesforthePreventionofTransmissionofInfectious
Diseases.NationalHealthandMedicalresearchCouncil.Rescinded.3 TheseguidelineswereselectedbasedonanalysisusingtheAGREEtool,whichensuresthatguidelineshavebeen
developedinarigorous,transparentandrobustmanner.ThisprocessisdiscussedindetailinAppendix2.
-
8/2/2019 ICG Draft 10jan10
15/210
CONSULTATIONDRAFTJANUARY2010
Introduction
15
Canad ian Critica l Care Trials Group
Com prehensive evidenc e-ba sed clinic al prac tice g uidelines for ventilator-assoc iated pne umonia: p revention
(2008)
Europe an Assoc iation o f Urology
Europea n and Asian guidelines on ma nag em ent an d p revention of ca thete r-assoc iated urinary tract infec tions
Sepa rate systema tic reviews of pub lished scientific and med ica l literature for areas of co ntroversy a nd c linica l
variation4
Alcohol products and other agents for hand hygiene
Infec tion co ntrol mea sures relate d to the use o f intrava sc ular device s
Positive p ressure room s in red uc ing risk for imm unoc om prom ised pa tients
Sta ff exclusion p olicies relat ing to norov irus ga stroen teritis
Persona l protec tive eq uipment in reduc ing the t ransmission of multi-resistant organ isms
Isolation m ea sures for p atients infec ted with va nco myc in-resistant enteroc oc ci or multi-resistant Gram neg ative
bacteria
Education interventions for the prevention of HAIs
Limitations of the grad ing proc ess as it applies to the prac tice of infec tion co ntrol
TherecommendationsintheseguidelineswereformulatedbytheInfectionControlSteeringCommittee5
throughaprocessofconsensus.Recommendationsaregivenwhenanactionisdeemedcriticaltopreventing
ormanaginginfection.RecommendationsaregradedaccordingtotherevisedNHMRCgradingsfor
assessingevidence,withtheadditionofgoodpracticepoints,whichoutlineactionsthatareessentialto
infectionpreventionandcontrolbutwhereevidencegradescannotbeapplied.
Inmanyareasofinfectioncontrol,theevidencemaybelimitedbytheinabilitytoconductcertainstudy
designsthataredifficulttoimplementinrealpractice.Thishasimplicationsforthelevelofgradingthatis
assignedtotherecommendations,sincegradingsystemswilltendtofavourstudydesignsthatare
sometimesnotfeasibleorunethicaltoconductininfectioncontrolsettingssuchasrandomisedcontrolled
trials.Forexample,itisunethicaltocomparetheincidenceofinfectionrelatedtosurgicalinstrumentsby
allocatingonepatientgrouptohavesterilisedinstrumentsusedonthemandonepatientgrouptohavenon
sterileinstruments
used
on
them.
This
may
result
in
alower
grading
due
to
the
available
evidence
but
sterilisationofsurgicalinstrumentsisuniversallydeemedcriticaltoinfectioncontrol.
Giventhatthereislimitedevidenceavailabletosupportmanyroutinepracticesintendedtoreduceinfection
risk,practiceisbasedondecisionsmadeonscientificprinciples.Someactivities,suchaspractisinghand
hygienebetweenadministeringcaretosuccessivepatients,haveacrediblehistorytosupporttheirroutine
applicationinpreventingcrossinfection.Others,suchassomeuniformandclothingrequirements,have
moretodowiththeethosofqualitycareandworkplaceculturethanwithaprovenreductionofcross
infection.
Itisnotacceptabletodiscontinuepracticesforwhichthereisasolidscientificbasis,evenifthelevelof
evidenceisnothigh.Rather,routinepracticesshouldcontinueunlessthereissufficientevidencetosupport
alternativeprocedures.
Continuing
research
is
needed
to
keep
evaluating
practice,
to
identify
evidence
gaps
andpromoteresearchintheseareas,andensurethatpoorpracticesdonotcontinue.
4 Duetoapaucityofevidenceorlowqualityevidencesomesystematicreviewswerenotusedtodraftrecommendations.
5 MembershipoftheInfectionControlSteeringCommitteeisgiveninAppendix1.
-
8/2/2019 ICG Draft 10jan10
16/210
CONSULTATIONDRAFTJANUARY2010
Introduction
16
Tab le 3: NHMRC grad es of evid enc e
Grade Description
A Body of evidenc e c an b e trusted to guide p rac tice
B Bod y of evidenc e c an b e trusted to guide prac tice in most situations
C Bod y of evidenc e p rovide s some supp ort for reco mm end ation(s) but c are should b e ta ken in
its ap plication
D Body o f evidence is wea k and reco mmend ation must be ap plied with caution
TheICGSteeringCommitteealsoassignedanadditionalgradereferredtoasgoodpracticepoints(GPPs):
GPP Bod y of evidenc e is wea k or non-existent. Rec omm end ation for be st prac tice b ased on
clinical experience and expert opinion
Struc ture of the guidelines
Theseguidelinesarebasedaroundthefollowingcoreprinciples:
anunderstandingofthemodesoftransmissionofinfectiousagentsandanoverviewofriskmanagement;
effectiveworkpracticesthatminimisetheriskofselectionandtransmissionofinfectiousagents;
governancestructures
that
support
the
implementation,
monitoring
and
reporting
of
infection
control
workpractices;and
compliancewithlegislation,regulationsandstandardsrelevanttoinfectioncontrol.
ThePartsofthedocumentarebasedonthesecoreprinciplesandareorganisedaccordingtothelikely
readership.
PartApresentsbackgroundinformationthatshouldbereadbyeveryoneworkinginhealthcare(for
exampleasorientationoraspartofannualreview)thisincludesimportantbasicsofinfectioncontrol,
suchasthemainmodesoftransmissionofinfectiousagentsandtheapplicationofriskmanagement
principles.Thispartoftheguidelinesdoesnotincluderecommendations.
PartBisspecifictothepracticeofhealthcareworkersandsupportstaff,andoutlineseffectivework
practicesthatminimisetheriskofselectionortransmissionofinfectiousagents.RecommendationsaregiveninSectionsB1toB3.Eachsectionincludesadviceonputtingtherecommendationsintopracticeandarisk
managementcasestudy.
SectionB1describesstandardprecautionsusedatalltimestominimisetheriskoftransmissionof
infectiousagents;
SectionB2outlinestransmissionbasedprecautionstoguidestaffinthepresenceofsuspectedorknown
infectiousagentsthatrepresentanincreasedriskoftransmission;
SectionB3outlinesapproachestothemanagementofmultiresistantorganisms(MROs)oroutbreak
situations;and
SectionB4outlinesprocessesforriskidentificationandtheapplicationofstandardandtransmission
basedprecautions
for
certain
procedures.
PartCdescribestheresponsibilitiesofmanagementofhealthcarefacilities,includinggovernance
structuresthatsupporttheimplementation,monitoringandreportingofeffectiveworkpractices.The
chaptersoutlinethemaincomponentsofasystemsapproachtofacilitywideinfectioncontrol,giving
guidanceonmanagementandstaffresponsibilities,protectionofhealthcareworkers,requirementsfor
educationandtrainingofallstaff,considerationsforfacilitydesignandrenovation,andotherimportant
activitiessuchassurveillanceandantibioticstewardship.
PartDprovidesexamplesofrelevantstandards,legislationandresources.
Theappendicesprovideadditionalinformationontheguidelinedevelopmentprocess,andsometoolsto
assistinapplyingtherecommendations.
Keyinformationishighlightedintheguidelinesasfollows.
-
8/2/2019 ICG Draft 10jan10
17/210
CONSULTATIONDRAFTJANUARY2010
Introduction
17
Tab le 4: Key to type s of informa tion highlighted in the guidelines
Summaries provide key information from ea c h sec tion of the g uidelines
Rec omm enda tions (Sec tions B1, B2 and B3) outline the c ritica l aspe c ts of infec tion p reve ntion a nd c ontrol
Patient c are tips highlight pa tient c onsiderations in the a pp lic ation o f infec tion c ontrol principles
Casestudiesillustratetheapplicationofriskmanagementprinciples(SectionsB1,B2andB3)andmeasuresto
supportgoodpractice(PartC)
Thefollowingtablesummarisesthekeytopicsdiscussedinthedocument.
-
8/2/2019 ICG Draft 10jan10
18/210
-
8/2/2019 ICG Draft 10jan10
19/210
CONSULTATIONDRAFTJANUARY2010
PART A BASICS OF INFECTION CONTROL
Hea lthca re-assoc iated infec tions (HAIs) ca n oc c ur in any hea lthca re setting . While the spec ific risks ma y
differ, the b asic principles of infec tion c ontrol ap ply reg ardless of the setting .
In orde r to p revent HAIs, it is impo rta nt to unde rsta nd ho w infec tions oc c ur in healthc a re sett ings and then
institute wa ys to p revent the m. Risk manage me nt is integral to this ap p roa ch.
If effec tively imp lemented , the two -tiered a pp roa c h of stand ard a nd transmission-ba sed prec autions
rec om mend ed in these guidelines provides high-level protec tion to pa tients, hea lthc are w orkers and
other pe op le in healthca re settings.
Infec tion control is integral to c linica l c a re a nd the way in which it is provided . It is not a n ad d itiona l set of
practices.
Involving p a tients is essential to suc c essful c linica l ca re. This inc lude s ensuring tha t pa tients rights a re
respe c ted at all times, that they a re involved in dec ision-ma king ab out the ir c are, and they a re suffic ientlyinformed to b e a b le to p articipa te in red uc ing the risk of transmission of infec tious ag ents.
The informat ion presente d in this Pa rt is releva nt to e verybo dy emp loyed b y a hea lthca re fa c ility, including
ma nag em ent, hea lthca re w orkers and supp ort servic e staff.
-
8/2/2019 ICG Draft 10jan10
20/210
-
8/2/2019 ICG Draft 10jan10
21/210
CONSULTATIONDRAFTJANUARY2010
Sec tion A1 Infec tion c ontrol in the hea lthcare setting
21
otherfactorsthatincreasetheriskoftransmissionofinfection(e.g.undergoingsurgery,requiringan
indwellingdevicesuchasacatheter,orremaininginhospitalforlengthyperiods).
Inhealthcaresettings,themostcommonsusceptiblehostsarepatientsandhealthcareworkers:
Patientsmaybeexposedtoinfectiousagentsfromthemselves(endogenousinfection)orfromother
people,instrumentsandequipment,ortheenvironment(exogenousinfection).Thelevelofriskrelatesto
thehealthcaresetting(specifically,thepresenceorabsenceofinfectiousagents),thetypeofhealthcare
proceduresperformedandthesusceptibilityofthepatient.
Healthcareworkersmaybeexposedtoinfectiousagentsfrominfectedorcolonisedpatients,instruments
andequipment,ortheenvironment.Thelevelofriskrelatestothetypeofclinicalcontacthealthcare
workershavewithpotentiallyinfectedorcolonisedpatientgroups,instrumentsorenvironments,andthe
healthstatusofthehealthcareworker(e.g.immunisedorimmunocompromised).
Inhealthcaresettings,themainmodesoftransmissionofinfectiousagentsarecontact(including
bloodborne),dropletandairborne.Themodesoftransmissionvarybytypeoforganism.Insomecasesthe
sameorganismmaybetransmittedbymorethanoneroute(e.g.norovirus,influenzaandrespiratory
syncytialvirus[RSV]canbetransmittedbycontactanddropletroutes).
A1.1.1 Routes of transmission
Conta c t transmission
Contactisthemostcommonmodeoftransmission,andusuallyinvolvestransmissionbyhandorviacontact
withbloodorbodysubstances.Contactmaybedirectorindirect.
Directtransmissionoccurswheninfectiousagentsaretransferredfromonepersontoanotherfor
example,apatientsbloodenteringahealthcareworkersbodythroughanunprotectedcutintheskin.
Indirecttransmissioninvolvesthetransferofaninfectiousagentthroughacontaminatedintermediate
objectorpersonforexample,ahealthcareworkershandstransmittinginfectiousagentsaftertouching
aninfectedbodysiteononepatientandnotperforminghandhygienebeforetouchinganotherpatient,or
ahealthcareworkercomingintocontactwithfomites(e.g.bedding)orfaecesandthenwithapatient.
Examplesof
infectious
agents
transmitted
by
contact
include
multi
resistant
organisms
(MROs),
Clostridiumdifficile,norovirusandhighlycontagiousskininfections/infestations(e.g.impetigo,scabies).
Drop let transmission
Droplettransmissioncanoccurwhenaninfectedpersoncoughs,sneezesortalks,andduringcertain
proceduressuchassuctioning.Dropletsareinfectiousparticleslargerthan5micronsinsize.Respiratory
dropletstransmitinfectionwhentheytraveldirectlyfromtherespiratorytractoftheinfectedpersonto
susceptiblemucosalsurfaces(nasal,conjunctivaeororal)ofanotherperson,generallyovershortdistances.
Dropletdistributionislimitedbytheforceofexpulsionandgravityandisusually1metreorless.However,
dropletscanalsobetransmittedindirectlytomucosalsurfaces(e.g.viahands).
Examplesofinfectiousagentsthataretransmittedviadropletsincludeinfluenzavirusandmeningococcus.
Airborne transmission
Airbornedisseminationmayoccurviaaerosols(smallairbornedropletslessthan5insize)containing
infectiousagentsthatremaininfectiveovertimeanddistance.Aerosolscanbegeneratedbycoughingand
sneezingandcertainprocedures,particularlythosethatinducecoughing,canpromoteairborne
transmission.Theseincludeproceduressuchasdiagnosticsputuminduction,bronchoscopy,airway
suctioning,endotrachealintubation,positivepressureventilationviafacemaskandhighfrequency
oscillatoryventilation.Aerosolscontaininginfectiousagentscanbedispersedoverlongdistancesbyair
currents(e.g.ventilationorairconditioningsystems)andinhaledbysusceptibleindividualswhohavenot
hadanycontactwiththeinfectiousperson.Thesesmallparticlescantransmitinfectionintosmallairwaysof
therespiratorytract.
Examplesofinfectiousagentsthataretransmittedviatheairbornerouteincludemeasles(rubeola)virus,
varicellavirusandM.tuberculosis.
-
8/2/2019 ICG Draft 10jan10
22/210
CONSULTATIONDRAFTJANUARY2010
Part A Basics of infec tion c ont rol
22
Other modes of transmission
Transmissionofinfectioncanalsooccurviacommonsourcessuchascontaminatedfood,water,
medications,devicesorequipment.
A1.2 STANDARD AND TRANSMISSION-BASED PRECAUTIONS
Successfulinfectioncontrolinvolvesimplementingworkpracticesthatpreventthetransmissionof
infectiousagentsthroughatwotieredapproachincluding:
routinelyapplyingbasicinfectioncontrolstrategiestominimiserisktobothpatientsandhealthcare
workers,suchashandhygiene,personalprotectiveequipment,cleaningandappropriatehandlingand
disposalofsharps(standardprecautions);and
effectivelymanaginginfectiousagentswherestandardprecautionsmaynotbesufficientontheirown.
Thesespecificinterventionscontrolinfectionbyinterruptingthemodeoftransmission(transmissionbased
precautions;formerlyreferredtoasadditionalprecautions).
Ifsuccessfullyimplemented,standardandtransmissionbasedprecautionspreventanytypeofinfectious
agentfrombeingtransmitted.
A1.2.1 Standard prec autions
Allpeoplepotentiallyharbourinfectiousagents.Workpracticestoensureabasiclevelofinfectioncontrol,
coveredbythetermstandardprecautions,areappliedtoeveryone,regardlessoftheirperceivedor
confirmedinfectiousstatus.Implementingstandardprecautionsasafirstlineapproachtoinfectioncontrol
inthehealthcareenvironmentminimisestheriskoftransmissionofinfectiousagentsfrompersontoperson,
eveninhighrisksituations.
Standardprecautionsareusedbyhealthcareworkerstopreventorreducethelikelihoodoftransmissionof
infectiousagentsfromonepersonorplacetoanother,andtorenderandmaintainobjectsandareasasfree
aspossiblefrominfectiousagents.
GuidanceonhowtoimplementstandardprecautionsisgiveninSectionB1.
Tab le A1.1: How stand ard prec autions are implem ented
Personal hygiene practices, particularly hand hygiene and cough etiquette, aim to reduce the risk of c ross-transmission a nd
c ross-infec tion o f infec tious agents (see Sec tion B1.1).
The use of personal protective equipment, which may include gloves, gowns, plastic aprons, masks/face-shields and eye
protec tion, aims to p revent expo sure of the hea lthcare wo rker to infectious ag ents (see Sec tion B1.2).
Appropriate hand ling a nd d isposal of sharps assist in preventing transmission of bloo d -bo rne d isea ses to hea lthca re wo rkers
(see Sec tion B1.3).
Environmental controls, inc luding c leaning a nd sp ills ma na ge me nt, assist in preve nting t ransmission of infec tious ag ents from
the e nvironment to p a tients (see Sec tion B1.4).
Appropriate reproce ssing of reusable eq uipment a nd instruments, including appropriate use of disinfectants, aims to
p revent p a tient-to -pa tient transmission of infec tious age nts (see Sec tion B1.5).
The a pp ropriate use o f aseptic and sterile techniques prevents conta mination of wound s and other susc ep tible sites by
infec tious agents (see Glossary).
-
8/2/2019 ICG Draft 10jan10
23/210
CONSULTATIONDRAFTJANUARY2010
Sec tion A1 Infec tion c ontrol in the hea lthcare setting
23
A1.2.2 Transmission-ba sed prec autions
Anyinfectioncontrolstrategyshouldbebasedontheuseofstandardprecautionsasaminimumlevelof
control.Transmissionbasedprecautionsarerecommendedasextraworkpracticesinsituationswhere
standardprecautionsalonemaybeinsufficienttopreventtransmission.Transmissionbasedprecautionsare
alsousedintheeventofanoutbreak(e.g.gastroenteritis),toassistincontainingtheoutbreakand
preventingfurtherinfection.
Transmissionbasedprecautionsshouldbetailoredtotheparticularinfectiousagentinvolvedanditsmode
oftransmission.Thismayinvolveacombinationofpractices.
GuidanceonwhenandhowtoimplementtransmissionbasedprecautionsisgiveninSectionsB2andB3
andAppendices3and4.
Tab le A1.2: Strategies for implem enting transmission-b ased p reca utions
Transmission-based prec autions may include one or any c om bination o f the following:
alloca ting a single room to a n infected pa tient (isolation);
plac ing pa tients c olonised or infec ted with the sam e infectious ag ent in a room tog ether (co horting);
wearing specific personal protective equipment;
providing dedica ted pa tient equipment;
using d isinfecta nts effec tive a ga inst the spe cific infectious ag ent;
providing a d edica ted to ilet;
use o f spe cific air hand ling tec hniques; and
restricting m ovem ent b oth o f pa tients and hea lthcare w orkers.
Contact p recautions are used w hen there is known or suspe c ted risk of transmission of infec tious age nts by d irec t or indirect
contac t (see Sec tion B2.2).
Droplet prec autions are used for pa tients known o r suspe ct ed to b e infecte d w ith age nts transmitted by respiratory droplets
(see Sec tion B2.3).
Airborne precautions are used for pa tients known o r suspe c ted to b e infect ed with ag ents transmitted pe rson-to-pe rson b y
the airbo rne route (see Sec tion B2.4).
-
8/2/2019 ICG Draft 10jan10
24/210
CONSULTATIONDRAFTJANUARY2010
Part A Basics of infec tion c ont rol
24
A2 OVERVIEW OF RISK MANAGEMENT IN INFECTION PREVENTION AND CONTROL
Summary
Identifying and ana lysing risks assoc iated with health c a re is an integ ra l pa rt of suc cessful infec tion c ontrol.
Ad op ting a risk ma nage me nt a pp roa c h a t a ll levels of the fac ility is nec essa ry. This task req uires the full
supp ort of the fac ilitys ma nag eme nt as well as c oop eration betw een ma nag eme nt, hea lthca re wo rkersand support staff.
A2.1 RISK MANAGEMENT BASICS
Inthecontextoftheseguidelines,riskisdefinedasthepossibilityofcolonisationorinfectionofpatientsor
healthcareworkersarisingfromactivitieswithinahealthcarefacility.Riskmanagementisthebasisfor
preventingandreducingharmsarisingfromhealthcareassociatedinfection.Asuccessfulapproachtorisk
managementoccursonmanylevelswithinahealthcarefacility:
facilitywideforexampleprovidingsupportforeffectiveriskmanagementthroughanorganisational
riskmanagementpolicy,stafftrainingandmonitoringandreporting;
wardordepartmentbasedforexampleembeddingriskmanagementintoallpoliciessothatrisksare
consideredineverysituation;
individualforexampleconsideringtherisksinvolvedincarryingoutaspecificprocedureand
questioningthenecessityoftheprocedureaspartofclinicaldecisionmaking,attendingeducation
sessions(e.g.handhygieneormaskfittraining).
TheAustralian/NewZealandStandardonRiskManagementAS/NZS4360:2004outlinesastepwise
approachtoriskmanagementthatallowscontinuousqualityimprovementandinvolves:
establishingcontextidentifyingthebasicparametersinwhichriskmustbemanaged(e.g.thetypeof
healthfacility,theextentofandsupportforthefacilitysinfectioncontrolprogram);
avoidingriskestablishingwhetherthereisariskandwhetherpotentialriskcanbeaverted(e.g.by
questioningwhetheraprocedureisnecessary);
identifyingrisksasystematicandcomprehensiveprocessthatensuresthatnopotentialriskisexcluded
fromfurtheranalysisandtreatment(e.g.usingrootcauseanalysis);
analysingrisksconsideringthesourcesofrisk,theirconsequences,thelikelihoodthatthose
consequencesmayoccur,andfactorsthataffectconsequencesandlikelihood(e.g.existingcontrols)(see
riskanalysismatrixbelow);
evaluatingriskscomparingthelevelofriskfoundduringtheanalysisprocesswithpreviously
establishedriskcriteria,resultinginaprioritisedlistofrisksforfurtheraction;and
treatingrisksselectingandimplementingappropriatemanagementoptionsfordealingwithidentified
risk(e.g.modifyingprocedures,protocolsorworkpractices;providingeducation;andmonitoring
compliancewith
infection
control
procedures).
Table A2.1: Risk ana lysis matrix
ConsequencesLikelihood
Negligible Minor Mod erate Major Extrem e
Rare Low Low Low Medium High
Unlikely Low Med ium Med ium High Very high
Possible Low Medium High Very high Very high
Likely Med ium High Very high Very high Extrem e
Almost certain Med ium Very high Very high Extrem e Extrem e
Low risk Mana ge by routine p rocedures.
Medium risk Manage by specific monitoring or audit procedures.
High risk
Very hig h risk
This is serious and must be add ressed imme d iate ly.
The ma gnitude o f the co nseq uenc es of an eve nt, should it occ ur, and the likelihood of that e vent
-
8/2/2019 ICG Draft 10jan10
25/210
CONSULTATIONDRAFTJANUARY2010
A2 Overview of risk mana ge ment in infec tion prevention and c ontrol
25
Extrem e risk oc curring, are a ssessed in the c ontext of the effe c tiveness of existing strate gies and c ont rols.
Monitoringandreviewisanessentialcomponentoftheriskmanagementprocess.Thisensuresthat:
newrisksareidentified;
analysisofriskisverifiedagainstrealdata,ifpossible;and
risk
treatment
is
implemented
effectively.
Communicationandconsultationarealsokeyelementsofclinicalriskmanagement.Aninteractiveexchange
ofinformationbetweenmanagement,healthcareworkers,patientsandotherstakeholdersprovidesthebasis
forincreasedawarenessoftheimportanceofinfectionpreventionandcontrol,identificationofrisksbefore
theyariseandpromptmanagementofrisksastheyoccur.
Thefollowingflowchartoutlineskeyconsiderationsduringtheprocessofriskmanagementinthecontextof
infectioncontrolinthehealthcaresetting.Casestudiesgivingexamplesofhowtousethisprocess,including
relevantconsiderationsinspecificsituations,areincludedinPartB.
Figure A1.1: Risk ma nage me nt flowc ha rt
Avoid riskAre there alte rna tive proc esses
or proce dures that wo uld
eliminate the risk?
If a risk c annot be eliminated then
it must be ma nage d
Identify risks
What infec tious age nt is involved?
How is it transmitted?
Who is at risk (patient and/or healthcare
worker)?
Treat risks
What will be do ne to a dd ress
risk?
Who ta kes responsibility?
How will c hang e be m onitored
and reviewed ?
Analyse risks
Why c an it happ en (ac tivities,
proc esses)?
How often could it happ en?
What are likely consequences?
Communicatea
ndconsult
Eva luate risks
What ca n be done to reduce o r
elimina te the risk?
How c ould this be ap plied in this
situa tion (sta ff, resource s)?
Monit
orandreview
-
8/2/2019 ICG Draft 10jan10
26/210
CONSULTATIONDRAFTJANUARY2010
Part A Basics of infec tion c ont rol
26
A3 A PATIENT-CENTRED APPROACH
Summary
A p atient-centred hea lth system is known to be assoc iated with safer a nd higher quality ca re.
A two -way a pp roa c h tha t enc ourage s pa tient pa rticipation is essential to suc c essful infec tion p revention
and co ntrol.
A3.1 PATIENT-CENTRED HEALTH CARE
Peoplereceivinghealthcareincreasinglyexpecttobegiveninformationabouttheirconditionandtreatment
optionsandthisextendstotheirrightsandresponsibilitiesasusersofhealthcareservices.Althoughpatient
satisfactionwithhealthservicesinAustraliaisgenerallyhigh,patientsexperiencesarenotalwaysvalued
andtheirexpectationsarenotalwaysmet.Whilethisdoesnotnecessarilyleadtopooroutcomesforthe
individualsconcerned,thebestpossibleoutcomesaremorelikelywherepatientcentredhealthcareisa
priorityofthehealthcarefacilityandastrongandconsistenteffortismadetorespectpatientsrightsand
expectations.
TheACSQHChasdevelopedanAustralianCharterofHealthcareRights,6whichrecognisesthatpeople
receivingcareandpeopleprovidingcareallhaveimportantpartstoplayinachievinghealthcarerights.The
Charterallowspatients,families,carersandservicesprovidinghealthcaretoshareanunderstandingofthe
rightsofpeoplereceivinghealthcare.TheCharterstipulatesthatallAustralianshavetherightto:
accessservicesthataddresstheirhealthcareneeds;
receivesafeandhighqualityhealthservices,providedwithprofessionalcare,skillandcompetence;
receivecarethatshowsrespecttothemandtheirculture,beliefs,valuesandpersonalcharacteristics;
receiveopen,timelyandappropriatecommunicationabouttheirhealthcareinawaytheycan
understand;
joininmakingdecisionsandchoicesabouttheircareandabouthealthserviceplanning; havetheirpersonalprivacyandpersonalhealthandotherinformationproperlyhandled;and
commentonorcomplainabouttheircareandhavetheirconcernsdealtwithproperlyandpromptly.
Patientcentredcarecannotjustbeaddedontousualcare.Therights,experiencesandviewsofpatients
shouldbeatthecentreofthecareprocessanddrivethewayinwhichcareisdelivered.Inmosthealthcare
facilities,asignificantculturechangeisnecessarytoembedpatientcentredcareprinciplesintothe
philosophyandpracticesoftheorganisation.Healthcareworkersandorganisationsneedtoacknowledge
andunderstandtheCharterofHealthcareRightsandworktoensurethatpatientsrightsareintegraltothe
careprocess.
A3.2 HOW DO ES PATIENT-CENTRED CARE RELATE TO INFECTION CONTROL?
Infectioncontrolisultimatelyaboutpeople.Effectiveinfectioncontroliscentraltoprovidinghighquality,
patientcentredhealthcare.
Puttingpatientsatthecentreofinfectioncontrolandenablingthemtoparticipateinthecareprocessisnot
justaboutexplainingtherisksoftreatments,butinvolvesconsideringpatientsneedsateverylevel.This
rangesfromdesigningthefacilitytomaximisepatientcomfortandsafetytohavingarangeofprocessesto
engagepatientsintheircareandlistenandactontheirfeedbackaswellasprovidingthepatientwith
educationandsupportsothattheycanbeinvolvedinlookingafterthemselves.
6 Availableat:http://www.safetyandquality.gov.au/internet/safety/publishing.nsf/Content/compubs_ACHR
roles/$File/17537charter.pdf
-
8/2/2019 ICG Draft 10jan10
27/210
CONSULTATIONDRAFTJANUARY2010
A3 A pa tient-centred a pp roach
27
Tosupportatwowayapproachtoinfectionpreventionandcontrolandencouragethepatientparticipation
requiredtopreventinfectionandminimisecrossinfection,itisimportantto:
takepatientsperspectivesintoaccountwhendevelopingpoliciesandprograms;
familiarisepatientswiththeinfectionpreventionandcontrolstrategiesthatareemployedinhealthcare
facilitiestoprotectthem,thepeoplecaringforthemandthehealthcareenvironment,andproceduresfor
dealingwithinfectioncontrolbreaches;
discusswithpatientsthespecificrisksassociatedwiththeirmedicaland/orsurgicaltreatment;
encouragepatientstodisclosetheirhealthorriskstatusifthereisapotentialriskorsourceofinfectionto
healthcareworkersorotherswithinthehealthcarefacility;
provideopportunitiesforpatientstoidentifyandcommunicaterisksandencouragethemtouse
feedbackproceduresforanyconcernsthattheyhaveaboutinfectionpreventionandcontrolprocedures;
provideeducationalmaterialsaboutinfectionpreventionandcontrolusingavarietyofmedia,including
postersinwaitingrooms,printedmaterialandeducationalvideos;and
informpatientsabouttheprotocolsforprotectingtheirprivacyandconfidentiality.
Specificguidanceonprovidingpatientcentredcareishighlightedthroughouttheguidelines,intextboxes,
inthePuttingitintopracticesectionattheendofeachchapterinPartB,andineachchapterofPartC.
Resourcesonhealthcarerights,culturalcompetence,andlinkstotoolsthataimtoassistdeliveryofpatient
centredcare,arelistedinPartD.
-
8/2/2019 ICG Draft 10jan10
28/210
CONSULTATIONDRAFTJANUARY2010
PART B STANDARD AND TRANSMISSION-BASED PRECAUTIONS
The use of sta ndard p rec au tions is the primary strategy for minimising the transmission o f healthc a re-associated infections.
Transmission-ba sed p rec au tions are used in ad d ition to sta ndard p reca utions, where the suspec ted or
known presence of infectious agents represents an increased risk of transmission.
The ap p lic at ion o f transmission-ba sed prec autions is pa rtic ularly imp ortan t in c onta ining multi-resistant
organisms (MROs) and in outbreak m ana ge ment.
Med ica l and denta l proced ures increa se the risk of transmission of infec tious ag ents. Effec tive wo rk
prac tice s to m inimise risk of transmission of infec tion related to proc ed ures req uire c onsiderat ion of t he
spe c ific situation, as we ll as app rop ria te use o f sta ndard and t ransmission-ba sed p rec autions.
Ap prop riate use o f asep tic t ec hnique a lso low ers the risk of infec tion risk by m inimising the numb er of
infec tious ag ents to whic h p atients are exposed . This c omp rises c lean te c hnique (stand ard prec autions
such as hand hyg iene, rep roc essing of e quipm ent b etw een pa tients, environme ntal c leaning) as a
minimum, as well as sterile technique to prevent infectious agents from entering a patients bloodstream
(e.g . use o f sterile instrume nts, d ressing m a teria ls and g love s, skin ant isep sis, and c rea tion o f a sterile field
within which to op erate).
The informa tion p resente d in this Part is pa rticula rly releva nt t o hea lthca re wo rkers and suppo rt sta ff. It outlines
effec tive w ork prac tice s tha t m inimise t he risk of transmission o f infec tious ag ents.
In a pp lying stand ard a nd transmission-ba sed infec tion c ontrols as part of d ay-to-da y p rac tice, hea lthc are
wo rkers should e nsure tha t their pa tients understand why c ertain prac tices are b eing und ertaken, and that
these p rac tices are in plac e to protec t eve ryone from infection. In this wa y, patients c an ta ke pa rt inminimising risks and question aspects of their care if necessary.
-
8/2/2019 ICG Draft 10jan10
29/210
CONSULTATIONDRAFTJANUARY2010
B1.1 Hand hygiene
29
B1 STANDARD PRECAUTIONS
Summary
It is essentia l tha t stand ard prec autions a re ap plied a t a ll time s. This is be c ause:
pe op le ma y be plac ed at risk of infec tion from others who c arry infec tious ag ents;
pe op le ma y be infec tious be fore signs or sympto ms of d isea se a re rec og nised or dete c ted , or before
labo rato ry tests are c onfirmed in time to c ontribute to c are;
pe op le ma y be a t risk from infec tious ag ents present in the surrounding environment includ ing
environmental surfaces or from equipment; and
there ma y be an inc reased risk of transmission assoc iated w ith spec ific proc ed ures and p rac tice s.
Sta ndard prec autions c onsist of the ap prop riate use o f four distinct interventions:
hand hygiene and coug h etiquette;
the use o f pe rsona l protec tive equipm ent;
the sa fe use and disposa l of sha rps; and
routine environme ntal c leaning.Hand hygiene p rac tice s are rec omm ended before and after every episode of pa tient c ontac t. Stand ard
prec autions should b e used in the hand ling o f:
blood (including dried blood);
all other bo dy fluids, sec retions and e xcretions (exclud ing swe a t), reg ardless of w hethe r they c ontain
visible bloo d ;
non-intac t skin; and
muc ous mem branes.
Ap prop riate d ispo sa l of hazardous ma terials (i.e. waste a nd linen) is a further imp ortant a spec t of infec tion
c ontrol. This is outside the sc op e o f these g uidelines and prac tice in these a rea s should ad here to releva nt
Australian standards.
Evidenc e supporting prac tice
Themajorityoftherecommendationsinthissectionhavebeenadaptedfrom:7
GraysonL,RussoP,RyanKetal(2009)HandHygieneAustraliaManual.AustralianCommissionforSafety
andQualityinHealthcareandWorldHealthOrganization;
UnitedStatesCentersforDiseaseControlandPrevention(CDC)GuidelineforIsolationPrecautions:
PreventingTransmissionofInfectiousAgentsinHealthcareSettings(2007);
Prattetal(2007)Epic2:NationalEvidenceBasedGuidelinesforPreventingHealthcareAssociatedInfectionsin
NHSHospitalsinEngland;and
WorldHealthOrganization(2009)GuidelinesonHandHygieneinHealth.
Furtherreviewoftheevidenceelicitedgoodqualityevidenceontheuseofalcoholbasedhandrubsin
reducingtransmissionofinfectiousagents.8
7 TheseguidelineswereselectedbasedonanalysisusingtheAGREEtool,whichensuresthatguidelineshavebeendevelopedinarigorous,transparentandrobustmanner.ThisprocessisdiscussedindetailinAppendix2.
8 ThereportofthisreviewisavailablefromtheNHMRCuponrequest.
-
8/2/2019 ICG Draft 10jan10
30/210
CONSULTATIONDRAFTJANUARY2010
B1 Stand ard prec aut ions
30
B1.1 HAND HYGIENE AND COUGH ETIQUETTE
B1.1.1 What are the risks?
Anyinfectiousagenttransmittedbythecontactordropletroutecanpotentiallybetransmittedbytouch.
Microorganismsareeitherpresentonthehandsmostofthetime(residentflora)oracquiredduring
activitiessuchashealthcare(transientflora).Handscanalsobecomecontaminatedthroughcontactwith
respiratorysecretions
when
coughing
or
sneezing.
Contaminated
hands
can
lead
to
cross
transmission
of
infectiousagentsinnonoutbreaksituations(Prattetal2001;CDC2002;Prattetal2007)andcontributeto
outbreaksinvolvingorganismssuchasmethicillinresistantStaphylococcusaureus(MRSA),vancomycin
resistantenterococci(VRE)andmultiresistantGramnegative(MRGN)microorganisms,suchas
Acinetobacterspp(Prattetal2001).
Figure B1.1: Imp ortanc e of hand hygiene
Theseimagesillustratethecriticalimportanceofhandhygieneincaringforpatients,includingthosenotknownto
carryantibioticresistantorganisms.Animprintofahealthcareworkersunglovedhandwasobtainedafterroutine
abdominalexaminationofapatientwithnohistoryofMRSAinfectionbutfoundonroutinesurveillancetohave
MRSAcolonisation.TheresultantcultureshowsMRSAcolonies(imageonleft).Anotherhandimprintobtainedafter
theworkershandhadbeencleanedwithalcoholbasedhandrubwasnegativeforMRSA(imageonright).
Source: DonskeyCJ&EcksteinBC(2009)Imagesinclinicalmedicine.Thehandsgiveitaway.NEnglJMed360(3):e3.
Improvedhandhygienepracticeshavebeenassociatedwith:
sustaineddecreasesintheincidenceofinfectionscausedbyMRSAandVRE(Websteretal1994;Zafaret
al1995;Maliketal1999;Larsonetal2000a;Pittetetal2000;Pittet&Boyce2001);
reductionsinhealthcareassociatedinfectionsofupto45%inarangeofhealthcaresettings(Fendleretal
2002;Pittetetal2000;Ryanetal2001);and
greaterthan50%reductionintheratesofnosocomialdiseaseassociatedwithMRSAandothermulti
resistantorganisms,after12years(Graysonetal2008;Johnsonetal2005).
Handhygienepracticesalonearenotsufficienttopreventandcontrolinfectionandneedtobeusedaspart
ofamultifactorialapproachtoinfectioncontrol.
B1.1.2 When should hand hyg iene be pe rformed ?
Handscanbecomecontaminatedwithinfectiousagentsthroughcontactwithapatient,patient
surroundings,the
environment,
or
other
healthcare
workers.
Cross
contamination
can
occur
from
one
site
to
anotherinthesamepatient,betweenhealthcareworkerandpatient,betweenpatientorhealthcareworker
andtheenvironment,orbetweenhealthcareworkers.Practicinghandhygienebeforeeveryepisodeofpatient
http://content.nejm.org/content/vol360/issue3/images/large/12f1.jpeghttp://content.nejm.org/content/vol360/issue3/images/large/12f1.jpeg -
8/2/2019 ICG Draft 10jan10
31/210
CONSULTATIONDRAFTJANUARY2010
B1.1 Hand hygiene
31
contact(includingbetweencaringfordifferentpatientsandbetweendifferentcareactivitiesforthesame
patient)andafteranyactivityorcontactthatpotentiallyresultsinhandsbecomingcontaminated(including
removalofgloves)reducestheriskofcrosscontamination.
The 5 mo me nts of hand hyg iene
The5momentsofhandhygienedevelopedbytheWorldHealthOrganizationandadoptedbyHand
HygieneAustralia
(Grayson
et
al
2009):
protectpatientsagainstacquiringinfectiousagentsfromthehandsofthehealthcareworker;
helptoprotectpatientsfrominfectiousagents(includingtheirown)enteringtheirbodiesduring
procedures;and
protecthealthcareworkersandthehealthcaresurroundingsfromacquiringpatientsinfectiousagents.
Figure B1.2: The 5 mom ents of ha nd hyg iene
Note: Handhygieneisalsoperformedaftertheremovalofgloves.
Source: Graysonetal2009.
RECOMMENDATION
1 Routine hand hyg iene Grade
Hand hygiene must be p erformed b efore and afte r eve ry episod e of pa tient co ntac t. Thisincludes:
before touching a pa tient;
before a proced ure;
after a p roc ed ure or bod y fluid expo sure risk;
after touching a pa tient; and
after touching a patients surroundings.
Hand hyg iene is also p erformed afte r the remo va l of g loves.
B
Cough e tiquette
Coveringsneezes
and
coughs
prevents
infected
persons
from
dispersing
respiratory
secretions
into
the
air.
Practisinghandhygieneaftercontactwithrespiratorysecretionsandcontaminatedobjectsormaterialsisan
essentialelementofcoughetiquette.
-
8/2/2019 ICG Draft 10jan10
32/210
CONSULTATIONDRAFTJANUARY2010
B1 Stand ard prec aut ions
32
Coughetiquetteisparticularlyimportantforpatientsondropletprecautions(seeSectionB2.3).
Tab le B1.1: Step s in c oug h etiq uette
Anyone with signs and symptoms of a respiratory infection, regardless of the cause, should follow or be instructed to follow
co ugh etiquette a s follows:
Cove r the nose/ mo uth when c oug hing or sneezing
Use tissues to c onta in respiratory sec retions
Dispo se o f tissues in the nea rest waste rec ep ta c le a fter use
If no tissues are a vailable, co ugh or sneeze into the inner elbow rather than the ha nd
Practice hand hygiene after contact with respiratory secretions and contaminated objects/materials
B1.1.3 What prod uc t should be used ?
Recentsystematicreviewsandexistingguidelines(Boyce&Pittet2002;Picheansathian2004;Prattetal2007;
CanadaStandardsandGuidelineCoreCommittee2008;Larmeretal2008;PIDAC2008;Graysonetal2009)
andother
available
review
articles
(Pittet
&
Boyce
2001;
Rotter
2004;
Nicolay
2006)
agree
that
hand
hygiene
usingalcoholbasedhandrubsismoreeffectiveagainstthemajorityofcommoninfectiousagentsonhands
thanhandhygienewithplainorantisepticsoapandwater.
Alcoholbasedhandrubs(liquidorgel)areeasilyaccessibleatpointofcareandhave(Graysonetal2009):
excellentantimicrobialactivityagainstGrampositiveandGramnegativevegetativebacteria,
Mycobacteriumtuberculosisandawiderangeoffungi;
generallygoodantimicrobialactivityagainstenvelopedviruses;
lesserand/orvariableantimicrobialactivityagainstnonenvelopedviruses(suchasnorovirus);and
noactivityagainstprotozoanoocystsandbacterialspores(suchasC.difficile)(seeSectionB2.2).
Therangeofantimicrobialactivityinalcoholbasedhandrubsvarieswiththealcoholcompound(ethanol,
isopropanolornpropanol)used.Alcoholbasedhandrubsthathave70%byvolume(v/v)ethanolor
equivalenthavesignificantlygreaterantimicrobialactivityagainstcommoninfectiousagentsthanthose
below70%v/vethanol(Picheansathian2004;CanadaStandardsandGuidelineCoreCommittee2008;
PIDAC2008).Theadditionofalowconcentrationofchlorhexidinetoanalcoholbasedhandrubenhances
residualactivity(Rotter2004;Graysonetal2009)buthasbeenassociatedwithskinsensitivity.
Alcoholbasedhandrubsdonotremovedirtorotherorganicmaterial,andcontinuedusemayleadto
productbuildupthatleavesaresidue,requiringhandhygienewithliquidsoapandwater.
Plainsoapsactbymechanicalremovalofmicroorganismsandhavenoantimicrobialactivity.Theyare
sufficientforgeneralsocialcontactandforcleansingofvisiblysoiledhands.Thereisatendencyfor
antimicrobialsoapstobemoreeffectivethanplainsoaps,althoughtheevidencearoundthisisinconsistent.
Antimicrobialsoapisassociatedwithskincareissuesanditisnotnecessaryforuseineverydayclinical
practice(Prattetal2001;CDC2002;Prattetal2007.)
RECOMMENDATIONS
2 Choice of produc t for routine hand hygiene prac tices Grade
Alcoho l-ba sed hand rubs conta ining at least 70% v/ v etha nol or eq uivalent should b e
used for all routine hand hygiene p rac tices in the hea lthcare environme nt.B
3 Choice of hand hygiene produc t when hands are visibly soiled
If hand s a re visibly soiled, hand hyg iene should be performed using soa p a nd wa ter. B
-
8/2/2019 ICG Draft 10jan10
33/210
CONSULTATIONDRAFTJANUARY2010
B1.1 Hand hygiene
33
Tec hnique
Effectivehandhygienereliesonappropriatetechniqueasmuchasonselectionofthecorrectproduct.Key
factorsineffectivehandhygieneandmaintainingskinintegrityinclude(CDC2002):
thedurationofhandhygienemeasures;
theexposureofallsurfacesofhandsandwriststothepreparationused(Widmer&Dangel2004);
theuseofvigorousrubbingtocreatefriction;and ensuringthathandsarecompletelydry.
Tab le B1.2: Use of alco hol-b ased hand rub
App ly the amo unt of alcohol-ba sed hand rub recom mend ed b y the manufac turer to dry hands.
Rub ha nds vigorously tog ether so tha t the solution c om es into co ntac t with all surfac es of the hand , pa ying p articular
atte ntion to the tips of the finge rs, the thumb s and the a reas be twe en the fingers.
Continue rubbing until the solution ha s eva po rated and the ha nds are d ry.
Tab le B1.3: Using soa p (includ ing antimic robial soap) and wa ter
Wet hands under tepid running w ater and ap ply the reco mmend ed amo unt of liquid soap .
Rub hand s vigorously toget her for a minimum of 15 sec ond s so tha t the solution c om es into c onta ct with a ll surfac es of
the ha nd, pa ying p articular attention to the tips of the fingers, the thumb s and the a reas be twe en the finge rs.
Rinse ha nds tho rough ly under running wa ter, then p a t d ry with single-use to we ls.
B1.1.4 Other aspec ts of hand hyg iene
Asintactskinisanaturaldefenceagainstinfection,cutsandabrasionsreducetheeffectivenessofhand
hygienepractices.Breaksorlesionsoftheskinarepossiblesourcesofentryforinfectiousagents(Larson
1996)andmayalsobeasourceofthem.Toreducetheriskofcrosstransmissionofinfectiousagents,cuts
andabrasionsshouldbecoveredwithwaterproofdressings.
Thetypeandlengthoffingernailscanhaveanimpactontheeffectivenessofhandhygiene(CDC2002;Lin
etal2003).Artificialnailshavebeenassociatedwithhigherlevelsofinfectiousagents,especiallyGram
negativebacilliandyeasts,thannaturalnails(Pottingeretal1989;Passaroetal1997;Focaetal2000;
Hedderwicketal2000;Moolenaaretal2000;Parryetal2001;CDC2002;Guptaetal2004;Boszczowskietal
2005).Fingernailsshouldthereforebekeptshortandcleanandartificialfingernailsshouldnotbeworn.
Althoughthereislessevidenceconcerningtheimpactofjewelleryontheeffectivenessofhandhygiene,
ringscaninterferewiththetechniqueusedtoperformhandhygieneresultinginhighertotalbacterialcounts
(CDC2002).Handcontaminationwithinfectiousagentsisincreasedwithringwearing(CDC2002;Tricket
al2003),althoughnostudieshaverelatedthispracticetohealthcareworkertopatienttransmission.
Wearingofjewelleryinclinicalareasshouldthereforebelimitedtoaplainband(e.g.weddingring)andthis
shouldbemovedaboutonthefingerduringhandhygienepractices.Inhighrisksettingssuchasoperating
suites/roomsthewearingofanyjewellery,evenaplainband,isnotrecommended.
B1.1.5 Hand care
Themaintypeofskinreactionassociatedwithhandhygiene,irritantcontactdermatitis,includessymptoms
suchasdryness,irritation,itchingandsometimescrackingandbleeding.Allergiccontactdermatitisisrare
andrepresentsanallergy,whichmaybetosomeingredientinahandhygieneproduct.
Generally,alcoholbasedhandrubscausesignificantlylessskindamagethanhandhygienewithplainor
antisepticsoaps(Pittet&Boyce2001).
-
8/2/2019 ICG Draft 10jan10
34/210
CON